Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Bass, Berry & Sims Announces New Corporate & Securities Practice Leadership

February 20, 2018

Nashville, Tenn., (February 20, 2018) – Bass, Berry & Sims PLC is pleased to announce that Kevin H. Douglas has been appointed to serve as chair of the firm's award-winning Corporate & Securities Practice Group. In this role, Douglas will work closely with firm management and with the more than 100 corporate attorneys and staff across the firm's four offices to develop goals and implement initiatives for the department that are in line with the firm's overall strategy. Douglas succeeds J. Allen Overby as chair, who served in this position for the past five years.

"Our Corporate and Securities group continues to be recognized nationally for its impressive work partnering with clients on their most important business objectives. Kevin will be a strong leader for this dynamic group of attorneys as we continue to grow our practice and serve our clients with excellence," said Todd Rolapp, the firm's managing partner. 

Douglas joined the firm in 2004 and has 20 years of experience representing companies on matters related to corporate and securities law. He works with public companies and other clients on corporate governance matters, securities laws compliance, mergers and acquisitions, corporate finance, and shareholder activism. Since 2016 he has served as co-editor of the firm's Securities Law Exchange blog, providing news and insights on a variety of corporate law matters.

"I am excited for the opportunity to work with my colleagues in this capacity," said Douglas. "I thank Allen for his tremendous service as chair over the last five years, and I look forward to leading my peers as we continue to offer the high level of quality client service that has been synonymous with Bass, Berry & Sims."

About Bass, Berry & Sims PLC
With more than 270 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims has been involved in some of the largest and most significant litigation matters, investigations and business transactions in the country. Bass, Berry & Sims currently serves as primary corporate and securities counsel to more than 35 public companies and has assisted in countless high-profile, high-stakes engagements. The firm is a leader in corporate law and has been recognized in several respected publications, such as The M&A Advisor, Chambers USA and Corporate Board Member. For more information, visit

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.